Effect of Adjunctive Oral Cannabidiol on Convulsive Seizure Frequency in Dravet Syndrome

This randomized clinical trial evaluates the efficacy and safety of 2 doses of a pharmaceutical formulation of cannabidiol vs placebo for adjunctive treatment of convulsive seizures in patients with Darvet syndrome.

Read the full article here

Related Articles